Company: SHPH
Filing Date: 2025-01-07
Form Type: 8-K
Source: 0001493152-25-001132
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-07
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On
December 31, 2024, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “ Company”), received a letter from
the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“ Nasdaq”) stating that for the 30 consecutive business
day period between November 15, 2024 to December 30, 2024 the Company’s common stock had failed to maintain a minimum closing bid
price of $1.00 per share, as required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the
“ Minimum Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has an initial period of 180
calendar days, or until June 30, 2025 (the “ Compliance Period”), to regain compliance with the Minimum Bid Price Requirement.
To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of
10 consecutive business days.

If
the Company does not regain compliance with the Minimum Bid Price Requirement by June 30, 2025, the Company may be eligible for an additional
180-day period to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value
of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid
Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period
by effecting a reverse stock split, if necessary.

If
the Company cannot regain compliance during the Compliance Period or any subsequently granted compliance period, Nasdaq will provide
the Company with notice that its common stock will be subject to delisting. At that time, the Company may appeal Nasdaq’s delisting
determination to a Nasdaq Hearings Panel.

Nasdaq’s
notice to the Company of noncompliance has no immediate effect on the listing of the Company’s common stock and its common stock
will continue to be listed on The Nasdaq Capital Market under the symbol “ SHPH.” There can be no assurance that the Company
will regain compliance with the Minimum Bid Price Requirement or maintain compliance with any of the other Nasdaq continued listing requirements.
The Company will continue to monitor the closing bid